Kavar Capital Partners Group, LLC Baxter International Inc Transaction History

Kavar Capital Partners Group, LLC

$630 Million
Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 5,473 shares of BAX stock, worth $189,584. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,473

Previous 6,098 10.25%

Holding current value

$189,584

Previous $203,000 1.97%

% of portfolio

0.03%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$32.85 - $40.26 $20,531 - $25,162	-625 Reduced 10.25%	5,473 $207,000
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $187,581 - $216,749	-4,952 Reduced 44.81%	6,098 $260,000
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $175,197 - $215,198	5,525 Added 100.0%	11,050 $427,000
Q4 2022 Feb 10, 2023	SELL	$49.7 - $57.71 $1.47 Million - $1.71 Million	-29,655 Reduced 84.3%	5,525 $281,000
Q3 2022 Nov 08, 2022	SELL	$53.86 - $66.8 $107,827 - $133,733	-2,002 Reduced 5.38%	35,180 $1.9 Million
Q2 2022 Aug 09, 2022	SELL	$63.83 - $80.0 $75,319 - $94,400	-1,180 Reduced 3.08%	37,182 $2.39 Million
Q4 2021 Jan 27, 2022	SELL	$74.57 - $87.19 $14,913 - $17,438	-200 Reduced 0.52%	38,362 $3.29 Million
Q3 2021 Nov 01, 2021	SELL	$73.77 - $83.61 $23,975 - $27,173	-325 Reduced 0.84%	38,562 $3.1 Million
Q2 2021 Aug 02, 2021	SELL	$80.5 - $88.01 $16,100 - $17,602	-200 Reduced 0.51%	38,887 $3.13 Million
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $129,845 - $146,251	-1,700 Reduced 4.17%	39,087 $3.3 Million
Q4 2020 Feb 05, 2021	BUY	$75.39 - $82.36 $3.07 Million - $3.36 Million	40,787 New	40,787 $3.27 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Account

Kavar Capital Partners Group, LLC Baxter International Inc Transaction History